Detalles de la búsqueda
1.
Preoperative CA 19-9 Predicts Disease Progression in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Analysis from the US HIPEC Collaborative.
Ann Surg Oncol
; 31(5): 3314-3324, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38310181
2.
Implementation of a Hepatocellular Carcinoma Screening Program for At-risk Patients Safety-Net Hospital: A Model for National Dissemination.
Ann Surg
; 276(3): 545-553, 2022 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35837969
3.
The Impact of Carbohydrate Antigen 19-9 on Survival in Patients with Clinical Stage I and II Pancreatic Cancer.
Ann Surg Oncol
; 29(13): 8536-8547, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36121582
4.
Implications of leukocytosis following distal pancreatectomy splenectomy (DPS) and association with postoperative complications.
J Surg Oncol
; 126(6): 1012-1020, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35765934
5.
Should Signet Ring Cell Histology Alter the Treatment Approach for Clinical Stage I Gastric Cancer?
Ann Surg Oncol
; 28(1): 97-105, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32524459
6.
Impact of Perioperative Blood Transfusions on Outcomes After Hyperthermic Intraperitoneal Chemotherapy: A Propensity-Matched Analysis.
Ann Surg Oncol
; 28(8): 4499-4507, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33507449
7.
Elderly Patients Benefit From Enhanced Recovery Protocols After Colorectal Surgery.
J Surg Res
; 266: 54-61, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33984731
8.
A novel preoperative risk score to optimize patient selection for performing concomitant liver resection with cytoreductive surgery/HIPEC.
J Surg Oncol
; 123(1): 187-195, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33002202
9.
Phase II Study of Preoperative Chemoradiotherapy with Oxaliplatin, Infusional 5-Fluorouracil, and Cetuximab Followed by Postoperative Docetaxel and Cetuximab in Patients with Adenocarcinoma of the Esophagus: A Trial of the ECOG-ACRIN Cancer Research Group (E2205).
Oncologist
; 25(1): e53-e59, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31227647
10.
CRS/HIPEC with Major Organ Resection in Peritoneal Mesothelioma Does not Impact Major Complications or Overall Survival: A Retrospective Cohort Study of the US HIPEC Collaborative.
Ann Surg Oncol
; 27(13): 4996-5004, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33073341
11.
Repeat Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Is Not Associated with Prohibitive Complications: Results of a Multiinstitutional Retrospective Study.
Ann Surg Oncol
; 27(13): 4883-4891, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32318945
12.
The Intersection of Age and Tumor Biology with Postoperative Outcomes in Patients After Cytoreductive Surgery and HIPEC.
Ann Surg Oncol
; 27(13): 4894-4907, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32378087
13.
Implications of Postoperative Complications for Survival After Cytoreductive Surgery and HIPEC: A Multi-Institutional Analysis of the US HIPEC Collaborative.
Ann Surg Oncol
; 27(13): 4980-4995, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32696303
14.
Optimal Surveillance Frequency After CRS/HIPEC for Appendiceal and Colorectal Neoplasms: A Multi-institutional Analysis of the US HIPEC Collaborative.
Ann Surg Oncol
; 27(1): 134-146, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31243668
15.
Predictors of Anastomotic Failure After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Does Technique Matter?
Ann Surg Oncol
; 27(3): 783-792, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31659645
16.
Preoperative Risk Score for Predicting Incomplete Cytoreduction: A 12-Institution Study from the US HIPEC Collaborative.
Ann Surg Oncol
; 27(1): 156-164, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31602579
17.
Receipt of Adjuvant Chemotherapy in Stage II Colon Cancer and Overall Survival: A National Cancer Database Study.
J Surg Res
; 252: 69-79, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32244127
18.
Predictors of Non-home Discharge after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
J Surg Res
; 255: 475-485, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32622162
19.
Institutional variation in recovery after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: An opportunity for enhanced recovery pathways.
J Surg Oncol
; 122(5): 980-985, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32627199
20.
A Novel Validated Recurrence Risk Score to Guide a Pragmatic Surveillance Strategy After Resection of Pancreatic Neuroendocrine Tumors: An International Study of 1006 Patients.
Ann Surg
; 270(3): 422-433, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31283562